These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease Study Group. Di Lenarda A; Sabbadini G; Salvatore L; Sinagra G; Mestroni L; Pinamonti B; Gregori D; Ciani F; Muzzi A; Klugmann S; Camerini F J Am Coll Cardiol; 1999 Jun; 33(7):1926-34. PubMed ID: 10362195 [TBL] [Abstract][Full Text] [Related]
5. Carvedilol improves left atrial and left ventricular function and reserve in dilated cardiomyopathy after 1 year of treatment. Paraskevaidis I; Farmakis D; Parissis JT; Dodouras T; Filippatos G; Tsiapras D; Kremastinos DT J Card Fail; 2007 Mar; 13(2):108-13. PubMed ID: 17395050 [TBL] [Abstract][Full Text] [Related]
6. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy. Lee YC Am J Cardiol; 1997 Apr; 79(7):1001. PubMed ID: 9104927 [No Abstract] [Full Text] [Related]
7. Effects of carvedilol in heart failure due to dilated cardiomyopathy. Results of a double-blind randomized placebo-controlled study (CARIBE study). Chizzola PR; Freitas HF; Caldas MA; da Costa JM; Meneghetti C; Marinho NV; Mansur AJ; Ramires JA; Bocchi EA Arq Bras Cardiol; 2000 Mar; 74(3):233-42. PubMed ID: 10951826 [TBL] [Abstract][Full Text] [Related]
9. [Reversibility of left ventricular dysfunction in elderly patients with dilated cardiomyopathy undergoing treatment with carvedilol. Report of a case]. Cioffi G; Stefenelli C Ital Heart J Suppl; 2001 Jun; 2(6):668-72. PubMed ID: 11460842 [TBL] [Abstract][Full Text] [Related]
10. What type of beta-blocker should be used to treat chronic heart failure? Bristow MR Circulation; 2000 Aug; 102(5):484-6. PubMed ID: 10920055 [No Abstract] [Full Text] [Related]
12. Comparison of effects of carvedilol versus metoprolol on cytokine levels in patients with idiopathic dilated cardiomyopathy. Ohtsuka T; Hamada M; Saeki H; Ogimoto A; Hiasa Go; Hara Y; Shigematsu Y; Hiwada K Am J Cardiol; 2002 Apr; 89(8):996-9. PubMed ID: 11950447 [No Abstract] [Full Text] [Related]
13. Carvedilol therapy in pediatric patients with dilated cardiomyopathy. Askari H; Semizel E; Bostan OM; Cil E Turk J Pediatr; 2009; 51(1):22-7. PubMed ID: 19378887 [TBL] [Abstract][Full Text] [Related]
14. Carvedilol reverses elevated pulmonary vascular resistance in a child with dilated cardiomyopathy. Horenstein MS; Ross RD; Singh TP; Epstein ML Pediatr Cardiol; 2002; 23(1):100-2. PubMed ID: 11922497 [TBL] [Abstract][Full Text] [Related]
15. Carvedilol--a wide therapeutic potential in cardiovascular syndromes. Introduction. Taylor SH; Storstein L Cardiology; 1993; 82 Suppl 3():1-2. PubMed ID: 8106157 [No Abstract] [Full Text] [Related]
16. Treatment of dilated cardiomyopathy with carvedilol in children. Erdoğan I; Ozer S; Karagöz T; Celiker A; Ozkutlu S; Alehan D Turk J Pediatr; 2009; 51(4):354-60. PubMed ID: 19950843 [TBL] [Abstract][Full Text] [Related]
17. Effects of carvedilol therapy on cardiac autonomic control, QT dispersion, and ventricular arrhythmias in children with dilated cardiomyopathy. Oflaz MB; Balli S; Kibar AE; Ece I; Akdeniz C; Tuzcu V Med Sci Monit; 2013 May; 19():366-72. PubMed ID: 23686300 [TBL] [Abstract][Full Text] [Related]
18. Three decades of clinical trials with beta-blockers: the contribution of the CAPRICORN trial and the effect of carvedilol on serious arrhythmias. Pratt CM J Am Coll Cardiol; 2005 Feb; 45(4):531-2. PubMed ID: 15708699 [No Abstract] [Full Text] [Related]